Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6757)
All Articles published online
|
Publishing Process of This Article
|
May 14, 2019 (publication date) through Jun 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Gong SS, Fan YH, Han QQ, Lv B, Xu Y. Nested case-control study on risk factors for opportunistic infections in patients with inflammatory bowel disease. World J Gastroenterol 2019; 25(18): 2240-2250 [PMID: 31143074 DOI: 10.3748/wjg.v25.i18.2240] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i18/2240.htm |
| Number | Citing Articles |
| 1 |
Ferdinando D’Amico, Stéphane Nancey, Silvio Danese, Laurent Peyrin-Biroulet. A Practical Guide for Faecal Calprotectin Measurement: Myths and Realities. Journal of Crohn's and Colitis 2021; 15(1): 152 doi: 10.1093/ecco-jcc/jjaa093
|
| 2 |
Shailesh Perdalkar, Pooja Basthi Mohan, Balaji Musunuri, Siddheesh Rajpurohit, Shiran Shetty, Krishnamurthy Bhat, Cannanore Ganesh Pai. Thiopurine therapy in inflammatory bowel disease in the pandemic era: Safe or unsafe?. International Immunopharmacology 2023; 116: 109597 doi: 10.1016/j.intimp.2022.109597
|
| 3 |
Scott D. Lee, Jessica R. Allegretti, Flavio Steinwurz, Susan B. Connelly, Nervin Lawendy, Jerome Paulissen, Krisztina B. Gecse. Tofacitinib as a maintenance therapy in patients with ulcerative colitis stratified by OCTAVE Sustain baseline Mayo endoscopic subscore. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-022-02508-2
|
| 4 |
Antonio Pizuorno Machado, Abdullah Salim Shaikh, Alice Saji, Malek Shatila, Isabella Glitza Oliva, Yinghong Wang, Anusha Shirwaikar Thomas. Outcomes of Budesonide as a Treatment Option for Immune Checkpoint Inhibitor-Related Colitis in Patients with Cancer. Cancers 2024; 16(10): 1919 doi: 10.3390/cancers16101919
|
| 5 |
Vincenzo Craviotto, Federica Furfaro, Laura Loy, Alessandra Zilli, Laurent Peyrin-Biroulet, Gionata Fiorino, Silvio Danese, Mariangela Allocca. Viral infections in inflammatory bowel disease: Tips and tricks for correct management. World Journal of Gastroenterology 2021; 27(27): 4276-4297 doi: 10.3748/wjg.v27.i27.4276
|
| 6 |
S. A. Tsvetikova, E. E. Kruglov, L. G. Danilov, D. S. Zilov, Yu. V. Myakisheva, M. A. Makarova, L. A. Kaftyreva, E. I. Koshel. Composition and Pathogenic Potential of Mucosal Microbiota in Ulcerative Colitis. Russian Journal of Bioorganic Chemistry 2024; 50(2): 582 doi: 10.1134/S1068162024110463
|
| 7 |
Anand Kumar, Tatiana Teslova, Erin Taub, Joshua D. Miller, Dana J. Lukin. Comorbid Diabetes in Inflammatory Bowel Disease Predicts Adverse Disease-Related Outcomes and Infectious Complications. Digestive Diseases and Sciences 2021; 66(6): 2005 doi: 10.1007/s10620-020-06439-4
|
| 8 |
Cátia Arieira, Francisca Dias de Castro, Tiago Cúrdia Gonçalves, Maria J. Moreira, José Cotter. Combination therapy in inflammatory bowel disease patients: do we need to maximize the dose of azathioprine?. Scandinavian Journal of Gastroenterology 2020; 55(8): 920 doi: 10.1080/00365521.2020.1792543
|
| 9 |
Maede Ghanaeipour, Nima Behnaminia, Erfan Khadem, Amirhossein Nafari. The Risk of Opportunistic Infections in Patients with Inflammatory
Bowel Disease. The International Journal of Gastroenterology and Hepatology Diseases 2022; 1(1) doi: 10.2174/2666290601666220124111511
|
| 10 |
Sheng-Bo Fang, Yan-Qing Song, Chun-Yan Zhang, Li-Bo Wang. Risk factors for Clostridioides difficile infection in children and adolescents with inflammatory bowel disease: a systematic review and meta-analysis. World Journal of Pediatrics 2022; 18(1): 27 doi: 10.1007/s12519-021-00486-1
|
| 11 |
Kathryn Gazelakis, Isabel Chu, Catherine Martin, Miles P. Sparrow. Infections in inflammatory bowel disease patients on immunomodulator and biologic therapy are not associated with high serum drug levels. Internal Medicine Journal 2024; 54(1): 139 doi: 10.1111/imj.16105
|
| 12 |
Jennie Clough, Michael Colwill, Andrew Poullis, Richard Pollok, Kamal Patel, Sailish Honap. Biomarkers in inflammatory bowel disease: a practical guide. Therapeutic Advances in Gastroenterology 2024; 17 doi: 10.1177/17562848241251600
|
| 13 |
Trusha Patel, Andrew B. Grossman. Updates in Healthcare Maintenance and Monitoring of Children with Inflammatory Bowel Disease in the Era of Biologic Therapies. Current Treatment Options in Pediatrics 2019; 5(4): 466 doi: 10.1007/s40746-019-00181-4
|
| 14 |
Luigi Marongiu, Sascha Venturelli, Heike Allgayer. Involvement of HHV-4 (Epstein–Barr Virus) and HHV-5 (Cytomegalovirus) in Inflammatory Bowel Disease and Colorectal Cancer: A Meta-Analysis. Cancers 2022; 14(20): 5085 doi: 10.3390/cancers14205085
|
| 15 |
Elisa Morales-Marroquin, Luyu Xie, Madhuri Uppuluri, Jaime P. Almandoz, Nestor de la Cruz-Muñoz, Sarah E. Messiah. Immunosuppression and Clostridioides (Clostridium) difficile Infection Risk in Metabolic and Bariatric Surgery Patients. Journal of the American College of Surgeons 2021; 233(2): 223 doi: 10.1016/j.jamcollsurg.2021.04.028
|